Identification | Back Directory | [Name]
CaproMorelin Tartrate | [CAS]
193273-69-7 | [Synonyms]
CS-2136 CP 424391-18 CP-424391 tartrate CaproMorelin Tartrate CP 424391-18; CP-424391 TARTRATE N-{2-[(3aS)-3a-benzyl-2-methyl-3-methylidene-2,3,3a,4,6,7-hexahydro-5H-pyrazolo[4,3-c]pyridin-5-yl]-1-(benzyloxy)-2-oxoethyl}-2-methylalaninamide 2,3-dihydroxybutanedioate (1:1) | [Molecular Formula]
C32H41N5O10 | [MOL File]
193273-69-7.mol | [Molecular Weight]
655.695 |
Chemical Properties | Back Directory | [Melting point ]
>150oC (dec.) | [storage temp. ]
Hygroscopic, -20°C Freezer, Under inert atmosphere | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [color ]
White to Light Yellow | [Water Solubility ]
H2O: 20mg/mL, clear | [Stability:]
Hygroscopic |
Hazard Information | Back Directory | [Uses]
Treatment
and prevention of frailty; treatment of congestive
heart failure; treatment of catabolic illness (growth
hormone secretagogue). | [Biological Activity]
Capromorelin tartrate is a potent ghrelin receptor agonist/growth hormone secretagogue (Ki = 7 nM). In r at pituitary cellsCapromorlelin incudes growth hormone (GH) secretion with an EC50 of 3 nM. Capromorelin also increases gastric motility and has been studied recently in patients with spinal cord injuries. | [storage]
Store at -20°C |
|
|